Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02246556 · ClinicalTrials.gov registry record · Phase 1
Dichoptic Virtual Reality Therapy for Amblyopia in Adults
A Phase 1 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT02246556 is a Phase 1 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 17 participants.
The verdict
NCT02246556, a Phase 1 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
This was a randomized, masked, controlled study of the effect of a virtual reality, binocular, 3-dimensional video game on visual acuity and stereopsis in adult patients with amblyopia. The trial has been halted as of June 2016 and will not be evaluating any new subjects for enrollment.
Interventions
- DEVICE Dichoptic therapy
- OTHER Patching therapy
- DEVICE Dioptic (non-dichoptic) therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02246556
The ClinicalTrials.gov registry entry for NCT02246556 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dichoptic therapy is the first listed.
NCT02246556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02246556 about?
NCT02246556 is a clinical study titled "Dichoptic Virtual Reality Therapy for Amblyopia in Adults". This was a randomized, masked, controlled study of the effect of a virtual reality, binocular, 3-dimensional video game on visual acuity and stereopsis in adult patients with amblyopia. The trial has been halted as of June 2016 and will not be evaluating any new subjects for enrollment.
What is the current status of trial NCT02246556?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2014-10. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02246556?
The interventions under investigation include: Dichoptic therapy (DEVICE), Patching therapy (OTHER), Dioptic (non-dichoptic) therapy (DEVICE).
Who is sponsoring clinical trial NCT02246556?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.